Format
Sort by
Items per page

Send to

Choose Destination

Best matches for hyponatremia cirrhosis:

Hyponatremia in cirrhosis: pathophysiology and management. John S et al. World J Gastroenterol. (2015)

Hyponatremia in Cirrhosis--Pathogenesis, Treatment, and Prognostic Significance. Sinha VK et al. Adv Chronic Kidney Dis. (2015)

Defining the role of albumin infusion in cirrhosis-associated hyponatremia. Nguyen MK et al. Am J Physiol Gastrointest Liver Physiol. (2014)

Search results

Items: 1 to 20 of 728

1.

Tolvaptan is effective in treating patients with refractory ascites due to cirrhosis.

Tahara T, Mori K, Mochizuki M, Ishiyama R, Noda M, Hoshi H, Lefor AK, Shinozaki S.

Biomed Rep. 2017 Dec;7(6):558-562. doi: 10.3892/br.2017.1005. Epub 2017 Oct 23.

2.

Impact of Acute Kidney Injury on Mortality of Patients Hospitalized for Complications of Cirrhosis.

Nuthalapati A, Schluterman N, Khanna A, Greenberg D, Thuluvath PJ.

J Clin Exp Hepatol. 2017 Dec;7(4):290-299. doi: 10.1016/j.jceh.2017.05.004. Epub 2017 May 13.

PMID:
29234192
3.

Utility of Tolvaptan in the Perioperative Management of Severe Hyponatremia During Liver Transplantation: A Case Report.

Parekh A, Rajaram P, Patel G, Subramanian RM.

Transplant Proc. 2017 Dec;49(10):2399-2401. doi: 10.1016/j.transproceed.2017.09.011.

PMID:
29198689
4.

Pirfenidone-induced hyponatraemia: insight in mechanism, risk factor and management.

Silhan L, Galiatsatos P, Corwine J, Danoff S.

BMJ Case Rep. 2017 Nov 27;2017. pii: bcr-2017-222734. doi: 10.1136/bcr-2017-222734.

PMID:
29183898
5.

Decompensated Cirrhosis and Fluid Resuscitation.

Maynard E.

Surg Clin North Am. 2017 Dec;97(6):1419-1424. doi: 10.1016/j.suc.2017.07.010. Epub 2017 Oct 5. Review.

PMID:
29132516
6.

Is Exaggerated Release of Arginine Vasopressin an Endocrine Disorder? Pathophysiology and Treatment.

Ishikawa SE.

J Clin Med. 2017 Oct 31;6(11). pii: E102. doi: 10.3390/jcm6110102. Review.

7.

Baseline Renal Function Predicts Hyponatremia in Liver Cirrhosis Patients Treated with Terlipressin for Variceal Bleeding.

Kim SE, Jung DM, Park JW, Ju Y, Lee B, Kim HS, Suk KT, Jang MK, Park SH, Kang JG, Soh JS, Lim H, Kang HS, Moon SH, Kim C, Lee S, Kim JH, Lee MS, Kim DJ, Ihm SH, Park C.

Gastroenterol Res Pract. 2017;2017:7610374. doi: 10.1155/2017/7610374. Epub 2017 Sep 17.

8.

Hepatic hydrothorax: About a hospital serie of 63 cases.

Mouelhi L, Daboussi O, Cheffi N, El Jery K, Said Y, Khedher S, Salem M, Dabbèche R, Houissa F, Najjar T.

Tunis Med. 2016 Dec;94(12):867.

9.

Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis.

Nakai M, Ogawa K, Takeda R, Ohara M, Kawagishi N, Izumi T, Umemura M, Ito J, Sho T, Suda G, Morikawa K, Sakamoto N.

Hepatol Res. 2017 Oct 6. doi: 10.1111/hepr.12988. [Epub ahead of print]

PMID:
28984014
10.

Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision.

Garioud A, Cadranel JF, Pauwels A, Nousbaum JB, Thévenot T, Dao T, Louvet A, Sogni P, Talbodec N, Antonini TM, Bureau C, Thabut D, Elkrief L, Jouannaud V, Macaigne G, Bernard-Chabert B, Lison H, Alric L, Carbonell N, Labadie H, Amiot X, Abergel A, Hanslik B, Leroy V, De Lédinghen V, Denis J; Association Nationale des Hépato-gastroentérologues des Hôpitaux Généraux de France, Association Française pour l’Etude du Foie, Club de Réflexion des Cabinets et Groupes d’Hépato-Gastroentérologie.

J Clin Gastroenterol. 2017 Aug 4. doi: 10.1097/MCG.0000000000000735. [Epub ahead of print]

PMID:
28953058
11.

The Outcome of Cirrhotic Patients with Ascites Is Improved by the Normalization of the Serum Sodium Level by Tolvaptan.

Kogiso T, Kobayashi M, Yamamoto K, Ikarashi Y, Kodama K, Taniai M, Torii N, Hashimoto E, Tokushige K.

Intern Med. 2017 Nov 15;56(22):2993-3001. doi: 10.2169/internalmedicine.9033-17. Epub 2017 Sep 25.

12.

Management of cirrhotic ascites in children: Review and recommendations. Part 2: Electrolyte disturbances, nonelectrolyte disturbances, therapeutic options.

Bes DF, Cristina Fernández M, Malla I, Repetto HA, Buamscha D, López S, Martinitto R, Cuarterolo M, Alvarez F.

Arch Argent Pediatr. 2017 Oct 1;115(5):505-511. doi: 10.5546/aap.2017.eng.505. English, Spanish.

13.

Continuous remission of renal cell carcinoma with tumour thrombus after severe adverse events following short-term treatment with sunitinib.

Kazama A, Katagiri A, Ishikawa S, Mizusawa T.

BMJ Case Rep. 2017 Aug 28;2017. pii: bcr-2017-221494. doi: 10.1136/bcr-2017-221494.

PMID:
28851716
14.

Management of ascites and hepatorenal syndrome.

Piano S, Tonon M, Angeli P.

Hepatol Int. 2017 Aug 23. doi: 10.1007/s12072-017-9815-0. [Epub ahead of print] Review.

PMID:
28836115
15.

Syndrome of inappropriate anti-diuresis induces volume-dependent hypercalciuria.

Grellier J, Jaafar A, Martin A, El Alaoui M, Lebely C, Tack I, Vallet M.

Osteoporos Int. 2017 Nov;28(11):3161-3168. doi: 10.1007/s00198-017-4186-x. Epub 2017 Aug 15.

PMID:
28812111
16.

Evaluation of Adrenal Function in Nonhospitalized Patients with Cirrhosis.

Moini M, Yazdani Sarvestani M, Shams M, Nomovi M.

Can J Gastroenterol Hepatol. 2017;2017:2354253. doi: 10.1155/2017/2354253. Epub 2017 Jul 24.

17.

Electrolytes: Sodium Disorders.

Braun MM, Mahowald M.

FP Essent. 2017 Aug;459:11-20. Review.

PMID:
28806046
18.

A mechanism based approach to management of children with end-stage liver disease.

Haafiz AB.

Expert Rev Gastroenterol Hepatol. 2017 Dec;11(12):1085-1094. doi: 10.1080/17474124.2017.1367662. Epub 2017 Aug 28.

PMID:
28803487
19.

Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision.

Garioud A, Cadranel JF, Pauwels A, Nousbaum JB, Thévenot T, Dao T, Louvet A, Sogni P, Talbodec N, Antonini TM, Bureau C, Thabut D, Elkrief L, Jouannaud V, Macaigne G, Bernard-Chabert B, Lison H, Alric L, Carbonell N, Labadie H, Amiot X, Abergel A, Hanslik B, Leroy V, De Lédinghen V, Denis J; Association Nationale des Hépato-gastroentérologues des Hôpitaux Généraux de France, Association Française pour l’Etude du Foie, Club de Réflexion des Cabinets et Groupes d’Hépato-Gastroentérologie.

J Clin Gastroenterol. 2017 Oct;51(9):831-838. doi: 10.1097/MCG.0000000000000735.

PMID:
28787354
20.

Performance of Disease-Specific Scoring Models in Intensive Care Patients with Severe Liver Diseases.

El-Ghannam MT, Hassanien MH, El-Talkawy MD, Saleem AAA, Sabry AI, Abu Taleb HM.

J Clin Diagn Res. 2017 Jun;11(6):OC12-OC16. doi: 10.7860/JCDR/2017/24543.9980. Epub 2017 Jun 1.

Supplemental Content

Loading ...
Support Center